Frontiers in Cardiovascular Medicine

MARCH 4, 2024

Atherosclerotic coronary artery disease (CAD) is the causal pathological process driving most major adverse cardiovascular events (MACE) worldwide. The complex development of atherosclerosis manifests as intimal plaque which occurs in the presence or absence of traditional risk factors.

Plaque 59

Plaque Coronary Artery Disease Blood Pressure Cardiovascular Disease 59

Cardiometabolic Health Congress

OCTOBER 25, 2024

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease.

CME 64

CME Innovation Education Atherosclerosis 64

Stroke Journal

FEBRUARY 1, 2024

Background:The association between left ventricular injury (LVI) detected by cardiac magnetic resonance imaging (CMR) and the risk of a subsequent ischemic stroke is unknown.Methods:We studied stroke-free participants in the Multi-Ethnic Study of Atherosclerosis study who underwent a steady-state free precession CMR at Exam 5 (2010-2012).

Atherosclerosis 40

Atherosclerosis Strokes Stroke BMI 40

European Journal of Heart Failure

NOVEMBER 3, 2024

Aims Abnormalities in specific echocardiographic parameters and cardiac biomarkers have been reported among individuals with diabetes. In this study, we developed and validated a machine learning-based clustering approach to identify the high-risk DbCM phenotype based on echocardiographic and cardiac biomarker parameters.

Cardiomyopathy 40

Cardiomyopathy Diabetes Biomarkers Atherosclerosis 40

Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.

Education 100

Education Innovation Risk Factors Obesity 100

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundAortic stenosis has pathophysiological similarities with atherosclerosis, including the deposition of cholesterol‐containing lipoproteins. The resulting cholesterol crystals activate the NLRP3 (NOD‐like receptor protein 3) inflammasome, leading to inflammation and cardiovascular diseases. mg/dL versus 97.9±37.6

Aortic valve 40

Aortic valve Cholesterol Aortic Stenosis 40

Dr. Paddy Barrett

AUGUST 22, 2023

However Most people do not appreciate that being a carrier of APOE4 significantly increases the risk of cardiovascular disease also. Share For those with defective LDL receptors, as seen in familial hyperlipidemia, APOB particles are not cleared effectively, and concentrations rise, causing atherosclerosis 4. J Mol Med (Berl).

Cholesterol 52

Cholesterol Dementia Cardiovascular Disease Coronary Artery Disease 52

Dr. Paddy Barrett

OCTOBER 31, 2023

They have the biomarker of risk but no evidence of the disease , even later in life when you would expect them to have it. When there is a history of early events, then the likelihood of a member of that family with an elevated Lp(a) having premature coronary atherosclerosis is high. Atherosclerosis. 2017 Jan;256:47-52.

Coronary Artery Disease 52

Coronary Artery Disease Heart Disease Atherosclerosis Cardiovascular Disease 52

Dr. Paddy Barrett

SEPTEMBER 19, 2023

Additionally, access to cholesterol synthesis biomarker testing, including desmosterol and lathosterol levels, can be challenging to obtain. Atherosclerosis. 9 Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. My approach for APOE 4 patients. Curr Opin Lipidol. N Engl J Med.

Dementia 52

Dementia Cholesterol Biomarkers Coronary Artery Disease 52

DAIC

JULY 23, 2024

The International Atherosclerosis Society (IAS) has released a clinical proceedings white paper outlining the role of inflammation in atherosclerosis and the importance of early intervention. Systemic, chronic inflammation can also promote the advancement of atherosclerosis and increase the risk of developing cardiovascular diseases.

Atherosclerosis 110

Atherosclerosis Cardiovascular Disease Biomarkers Hospital 110

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

DAIC

FEBRUARY 1, 2024

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market. per 1,000* - 122.4

Cardiovascular Disease 104

Cardiovascular Disease Atherosclerosis Strokes Stroke 104

DAIC

JANUARY 30, 2024

Clinicians currently use two separate risk models to assess patients’ chances of having heart attacks , strokes , and other major cardiovascular events. Clinicians currently use two separate risk models to assess patients’ chances of having heart attacks , strokes , and other major cardiovascular events.

Cardiovascular Disease 52

Cardiovascular Disease Research Heart attacks Heart Attack 52

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Objective Arterial stiffness is an important tissue biomarker of the progression of atherosclerotic diseases. Methods We included 94 subjects free of apparent cardiovascular disease (CVD) and divided them into a subclinical atherosclerosis (SA) group ( N  = 47) and non subclinical atherosclerosis (NSA) group ( N  = 47).

Atherosclerosis 64

Atherosclerosis Biomarkers Cardiovascular Disease 64

All About Cardiovascular System and Disorders

DECEMBER 15, 2023

CLEAR trial was a double blind, randomized, placebo controlled trial of patients who were unable or unwilling to take statins due to unacceptable adverse effects and had or were at high risk for cardiovascular disease. CLEAR trial had patients for both primary and secondary prevention of cardiovascular disease.

Cholesterol 52

Cholesterol Myocardial Infarction Cardiovascular Disease Diabetes 52

Physiologically Speaking

MAY 17, 2024

Most of the evidence on the harms of extreme exercise is related to a biomarker of cardiovascular disease known as coronary artery calcification or CAC. Exercise and Coronary Atherosclerosis | Circulation What’s lacking, however, is good data on long-term survival and lifespan among “extreme exercisers.”

Physiology 98

Physiology Exercise Biomarkers Cardiovascular Disease 98

Physiologically Speaking

APRIL 24, 2024

” ―William Shakespeare, Macbeth Sleep and cardiovascular disease: the epidemiological evidence Despite our knowledge that sleep is vital for human health and well being, we often neglect it. 7 8 [link] Short sleep duration may also affect biomarkers related to vascular function. More than one-third of U.S.

Blood Pressure 52

Blood Pressure Blood Clot COVID-19 Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

NOVEMBER 1, 2024

BackgroundAtherosclerosis is a leading cause of cardiovascular disease worldwide, while carotid atherosclerosis (CAS) is more likely to cause ischemic cerebrovascular events. Emerging evidence suggests that cuproptosis may be associated with an increased risk of atherosclerotic cardiovascular disease.

Atherosclerosis 52

Atherosclerosis Cardiovascular Disease Plaque Biomarkers 52

Physiologically Speaking

DECEMBER 17, 2024

Coronary artery calcium (CAC) is a measure of atherosclerosis and a strong predictor of cardiovascular disease. This finding might seem alarming since higher CACS is generally associated with an elevated risk of cardiovascular disease (CVD). A new analysis helps us understand.

Risk Factors 105

Risk Factors Genetic predisposition Plaque Exercise 105

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection.

CME 103

CME Obesity Heart Failure Biomarkers 103